<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35210363</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1091-6490</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>119</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
          <ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e2112840119</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2112840119</ELocationID>
        <Abstract>
          <AbstractText>Cancer-associated cachexia (CAC) is a hypermetabolic syndrome characterized by unintended weight loss due to the atrophy of adipose tissue and skeletal muscle. A phenotypic switch from white to beige adipocytes, a phenomenon called browning, accelerates CAC by increasing the dissipation of energy as heat. Addressing the mechanisms of white adipose tissue (WAT) browning in CAC, we now show that cachexigenic tumors activate type 2 immunity in cachectic WAT, generating a neuroprotective environment that increases peripheral sympathetic activity. Increased sympathetic activation, in turn, results in increased neuronal catecholamine synthesis and secretion, β-adrenergic activation of adipocytes, and induction of WAT browning. Two genetic mouse models validated this progression of events. 1) Interleukin-4 receptor deficiency impeded the alternative activation of macrophages, reduced sympathetic activity, and restrained WAT browning, and 2) reduced catecholamine synthesis in peripheral dopamine β-hydroxylase (DBH)-deficient mice prevented cancer-induced WAT browning and adipose atrophy. Targeting the intraadipose macrophage-sympathetic neuron cross-talk represents a promising therapeutic approach to ameliorate cachexia in cancer patients.</AbstractText>
          <CopyrightInformation>Copyright © 2022 the Author(s). Published by PNAS.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Hao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heier</LastName>
            <ForeName>Christoph</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Xia</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Tsinghua University, 100190 Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bakiri</LastName>
            <ForeName>Latifa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Genes and Disease Group, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pototschnig</LastName>
            <ForeName>Isabella</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Zhiyuan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Affiliated Hospital of Nantong University, 226001 Nantong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schauer</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Diagnostic and Research Institute of Pathology, Medical University Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baumgartner</LastName>
            <ForeName>Vanessa J</ForeName>
            <Initials>VJ</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grabner</LastName>
            <ForeName>Gernot F</ForeName>
            <Initials>GF</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schabbauer</LastName>
            <ForeName>Gernot</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-7490-8009</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Physiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolinski</LastName>
            <ForeName>Heimo</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robertson</LastName>
            <ForeName>Graham R</ForeName>
            <Initials>GR</Initials>
            <AffiliationInfo>
              <Affiliation>Lyramid Ltd, Sydney, 2000 NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoefler</LastName>
            <ForeName>Gerald</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Diagnostic and Research Institute of Pathology, Medical University Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Wenwen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Tsinghua University, 100190 Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wagner</LastName>
            <ForeName>Erwin F</ForeName>
            <Initials>EF</Initials>
            <Identifier Source="ORCID">0000-0001-7872-0196</Identifier>
            <AffiliationInfo>
              <Affiliation>Genes and Disease Group, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genes and Disease Group, Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schweiger</LastName>
            <ForeName>Martina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria; tina.schweiger@uni-graz.at rudolf.zechner@uni-graz.at.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Field of Excellence BioHealth, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>BioTechMed-Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zechner</LastName>
            <ForeName>Rudolf</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-5483-1182</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria; tina.schweiger@uni-graz.at rudolf.zechner@uni-graz.at.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Field of Excellence BioHealth, University of Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>BioTechMed-Graz, 8010 Graz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
        <NlmUniqueID>7505876</NlmUniqueID>
        <ISSNLinking>0027-8424</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011943">Receptors, Adrenergic, beta</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002001" MajorTopicYN="N">Adipose Tissue, Brown</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002100" MajorTopicYN="N">Cachexia</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002450" MajorTopicYN="Y">Cell Communication</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064593" MajorTopicYN="N">Heterografts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011943" MajorTopicYN="N">Receptors, Adrenergic, beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013564" MajorTopicYN="N">Sympathetic Nervous System</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022722" MajorTopicYN="N">Thermogenesis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">adipose tissue</Keyword>
        <Keyword MajorTopicYN="Y">browning</Keyword>
        <Keyword MajorTopicYN="Y">cancer cachexia</Keyword>
        <Keyword MajorTopicYN="Y">immunometabolism</Keyword>
        <Keyword MajorTopicYN="Y">macrophage</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35210363</ArticleId>
        <ArticleId IdType="pmc">PMC8892347</ArticleId>
        <ArticleId IdType="doi">10.1073/pnas.2112840119</ArticleId>
        <ArticleId IdType="pii">2112840119</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Porporato P. E., Understanding cachexia as a cancer metabolism syndrome. Oncogenesis
5, e200–e210 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5154342</ArticleId>
            <ArticleId IdType="pubmed">26900952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Haehling S., Anker S. D., Cachexia as a major underestimated and unmet medical need: Facts and numbers. J. Cachexia Sarcopenia Muscle
1, 1–5 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3060651</ArticleId>
            <ArticleId IdType="pubmed">21475699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petruzzelli M., et al. , A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab.
20, 433–447 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25043816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kir S., et al. , Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature
513, 100–104 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4224962</ArticleId>
            <ArticleId IdType="pubmed">25043053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arora G. K., et al. , Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin. JCI Insight
3, e121221 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6124433</ArticleId>
            <ArticleId IdType="pubmed">30046014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elattar S., Dimri M., Satyanarayana A., The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting. FASEB J.
32, 4727–4743 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6266632</ArticleId>
            <ArticleId IdType="pubmed">29570397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suriben R., et al. , Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat. Med.
26, 1264–1270 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32661391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baracos V. E., Martin L., Korc M., Guttridge D. C., Fearon K. C. H., Cancer-associated cachexia. Nat. Rev. Dis. Primers
4, 17105 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29345251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petruzzelli M., Wagner E. F., Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev.
30, 489–501 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4782044</ArticleId>
            <ArticleId IdType="pubmed">26944676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strassmann G., Fong M., Kenney J. S., Jacob C. O., Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest.
89, 1681–1684 (1992).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC443047</ArticleId>
            <ArticleId IdType="pubmed">1569207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rupert J. E., et al. , Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J. Exp. Med.
218, e20190450 (2021).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8185651</ArticleId>
            <ArticleId IdType="pubmed">33851955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baltgalvis K. A., et al. , Interleukin-6 and cachexia in Apc Min/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol.
294, R393–R401 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18056981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong N., et al. , Serum PTHrP predicts weight loss in cancer patients independent of hypercalcemia, inflammation, and tumor burden. J. Clin. Endocrinol. Metab.
101, 1207–1214 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26765580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita J., et al. , Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways. Int. J. Cancer
68, 637–643 (1996).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8938147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaki M. H., Nemeth J. A., Trikha M., CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice. Int. J. Cancer
111, 592–595 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15239138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalal S., Lipid metabolism in cancer cachexia. Ann. Palliat. Med.
8, 13–23 (2019).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30525767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agustsson T., et al. , Mechanism of increased lipolysis in cancer cachexia. Cancer Res.
67, 5531–5537 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17545636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsoli M., et al. , Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation. PLoS One
9, e92966 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3965507</ArticleId>
            <ArticleId IdType="pubmed">24667661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das S. K., et al. , Adipose triglyceride lipase contributes to cancer-associated cachexia. Science
333, 233–238 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21680814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohm M., Zeigerer A., Machado J., Herzig S., Energy metabolism in cachexia. EMBO Rep.
20, e47258 (2019).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6446208</ArticleId>
            <ArticleId IdType="pubmed">30890538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee Y. H., Mottillo E. P., Granneman J. G., Adipose tissue plasticity from WAT to BAT and in between. Biochim. Biophys. Acta
1842, 358–369 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4435780</ArticleId>
            <ArticleId IdType="pubmed">23688783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J., et al. , Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor. Cancer Cell
33, 770–784 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5896786</ArticleId>
            <ArticleId IdType="pubmed">29634950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patsouris D., et al. , Burn induces browning of the subcutaneous white adipose tissue in mice and humans. Cell Rep.
13, 1538–1544 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4662886</ArticleId>
            <ArticleId IdType="pubmed">26586436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sidossis L. S., et al. , Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress. Cell Metab.
22, 219–227 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4541608</ArticleId>
            <ArticleId IdType="pubmed">26244931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shellock F. G., Riedinger M. S., Fishbein M. C., Brown adipose tissue in cancer patients: Possible cause of cancer-induced cachexia. J. Cancer Res. Clin. Oncol.
111, 82–85 (1986).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3949854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deboer M. D., Animal models of anorexia and cachexia. Expert Opin. Drug Discov.
4, 1145–1155 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2771941</ArticleId>
            <ArticleId IdType="pubmed">20160874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose-John S., IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci.
8, 1237–1247 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3491447</ArticleId>
            <ArticleId IdType="pubmed">23136552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson S., Jones H. A., Göransson O., Degerman E., Holm C., Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase. Cell. Signal.
28, 204–213 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26724218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H., Ding X., Cao Y., Wang H., Zeng W., Dense intra-adipose sympathetic arborizations are essential for cold-induced beiging of mouse white adipose tissue. Cell Metab.
26, 686–692 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28918935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao L., et al. , White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab.
14, 324–338 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3172615</ArticleId>
            <ArticleId IdType="pubmed">21907139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vargovic P., et al. , Adipocytes as a new source of catecholamine production. FEBS Lett.
585, 2279–2284 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21689652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng W., et al. , Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell
163, 84–94 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26406372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu Y., et al. , Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell
157, 1292–1308 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4129510</ArticleId>
            <ArticleId IdType="pubmed">24906148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer K., et al. , Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis. Nat. Med.
23, 623–630 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5420449</ArticleId>
            <ArticleId IdType="pubmed">28414329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Y., Wang H., Zeng W., Whole-tissue 3D imaging reveals intra-adipose sympathetic plasticity regulated by NGF-TrkA signal in cold-induced beiging. Protein Cell
9, 527–539 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5966360</ArticleId>
            <ArticleId IdType="pubmed">29589323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goslin K., Schreyer D. J., Skene J. H. P., Banker G., Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature
336, 672–674 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3059197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matheis F., et al. , Adrenergic signaling in muscularis macrophages limits infection-induced neuronal loss. Cell
180, 64–78.e16 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7271821</ArticleId>
            <ArticleId IdType="pubmed">31923400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kigerl K. A., et al. , Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci.
29, 13435–13444 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788152</ArticleId>
            <ArticleId IdType="pubmed">19864556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batista M. L. Jr., et al. , Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients. J. Cachexia Sarcopenia Muscle
7, 37–47 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4799865</ArticleId>
            <ArticleId IdType="pubmed">27066317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J., et al. , The effects of the M2a macrophage-induced axonal regeneration of neurons by arginase 1. Biosci. Rep.
40, BSR20193031 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7012653</ArticleId>
            <ArticleId IdType="pubmed">31994698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foley K. P., et al. , Inflammation promotes adipocyte lipolysis via IRE1 kinase. J. Biol. Chem.
296, 100440 (2021).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8010698</ArticleId>
            <ArticleId IdType="pubmed">33610548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurencikiene J., et al. , NF-kappaB is important for TNF-α-induced lipolysis in human adipocytes. J. Lipid Res.
48, 1069–1077 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17272828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biswas A. K., Acharyya S., Cancer-associated cachexia: A systemic consequence of cancer progression. Annu. Rev. Cancer Biol.
4, 391–411 (2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Kir S., et al. , PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab.
23, 315–323 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4749423</ArticleId>
            <ArticleId IdType="pubmed">26669699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brooks A. E. S., et al. , Ex vivo human adipose tissue derived mesenchymal stromal cells (ASC) are a heterogeneous population that demonstrate rapid culture-induced changes. Front. Pharmacol.
10, 1695 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7044177</ArticleId>
            <ArticleId IdType="pubmed">32153389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramakrishnan V. M., Boyd N. L., The adipose stromal vascular fraction as a complex cellular source for tissue engineering applications. Tissue Eng. Part B Rev.
24, 289–299 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6080106</ArticleId>
            <ArticleId IdType="pubmed">28316259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larabee C. M., Neely O. C., Domingos A. I., Obesity: A neuroimmunometabolic perspective. Nat. Rev. Endocrinol.
16, 30–43 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31776456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coats A. J. S., et al. , Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: A randomized, multicentre phase II study (the ACT-ONE trial). J. Cachexia Sarcopenia Muscle
7, 355–365 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4929828</ArticleId>
            <ArticleId IdType="pubmed">27386169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark A. L., et al. , Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: Results from the COPERNICUS trial. J. Cachexia Sarcopenia Muscle
8, 549–556 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5566644</ArticleId>
            <ArticleId IdType="pubmed">28244261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fabbiano S., et al. , Caloric restriction leads to browning of white adipose tissue through type 2 immune signaling. Cell Metab.
24, 434–446 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27568549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdullahi A., et al. , Alternatively activated macrophages drive browning of white adipose tissue in burns. Ann. Surg.
269, 554–563 (2019).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7805006</ArticleId>
            <ArticleId IdType="pubmed">28817438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braune J., et al. , IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity. J. Immunol.
198, 2927–2934 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28193830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mauer J., et al. , Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol.
15, 423–430 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4161471</ArticleId>
            <ArticleId IdType="pubmed">24681566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai D., et al. , Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron
35, 711–719 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12194870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shan B., et al. , The metabolic ER stress sensor IRE1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity. Nat. Immunol.
18, 519–529 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28346409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon M. J., et al. , CCL2 mediates neuron-macrophage interactions to drive proregenerative macrophage activation following preconditioning injury. J. Neurosci.
35, 15934–15947 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6605453</ArticleId>
            <ArticleId IdType="pubmed">26631474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gervasi N. M., et al. , The local expression and trafficking of tyrosine hydroxylase mRNA in the axons of sympathetic neurons. RNA
22, 883–895 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4878614</ArticleId>
            <ArticleId IdType="pubmed">27095027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson M., Tourtellotte W., Neuron culture from mouse superior cervical ganglion. Bio Protoc.
4, e1035 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4819978</ArticleId>
            <ArticleId IdType="pubmed">27054145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cook H. C., Origins of ... tinctorial methods in histology. J. Clin. Pathol.
50, 716–720 (1997).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC500167</ArticleId>
            <ArticleId IdType="pubmed">9389971</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
